Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,488 papers from all fields of science
Search
Sign In
Create Free Account
ardeparin
Known as:
ardeparin [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Broader (3)
Anticoagulants
Fibrinolytic Agents
Heparin, Low-Molecular-Weight
Drug Allergy
Hemorrhagic Disorders
Postoperative Complications
Pulmonary Embolism
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer
Nusrat A. Motlekar
,
K. Srivenugopal
,
M. Wachtel
,
B. Youan
Drug development research (Print)
2006
Corpus ID: 38262534
Low molecular weight heparin (LMWH) is the agent of choice for anticoagulant therapy and prophylaxis of thrombosis and coronary…
Expand
2005
2005
RETRACTED: Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels
Nusrat A. Motlekar
,
K. Srivenugopal
,
M. Wachtel
,
B. Youan
Journal of drug targeting (Print)
2005
Corpus ID: 9024869
RETRACTED
Review
2002
Review
2002
Oral heparins.
L. Hiebert
Clinical Laboratory
2002
Corpus ID: 20167166
The antithrombotic drug heparin is administered parenterally and believed not effective orally. Oral heparin would be most…
Expand
2001
2001
Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist.
S. Ahmad
,
W. Jeske
,
Q. Ma
,
Jeanine M. Walenga
,
Jawed Fareed
Thrombosis Research
2001
Corpus ID: 22215658
Review
2001
Review
2001
Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism.
D. Ornstein
,
Y. G. Hong-Dice
,
J. R. Papini
Military Medicine
2001
Corpus ID: 12913693
Low-molecular-weight heparins (LMWHs) are rapidly becoming the anticoagulants of choice for the prevention and treatment of…
Expand
Review
2000
Review
2000
Ardeparin and danaparoid.
Dimensions of critical care nursing : DCCN
2000
Corpus ID: 37721296
1999
1999
Pharmacologic profile of certoparin.
W. Jeske
,
H. Wolf
,
A. Ahsan
,
J. Fareed
Expert Opinion on Investigational Drugs
1999
Corpus ID: 22478148
The low molecular weight heparins (LMWHs) are now not only used for the prophylaxis and treatment of deep vein thrombosis (DVT…
Expand
Review
1999
Review
1999
Low molecular weight heparins in the outpatient management of venous thromboembolism.
R. Bick
Seminars in Thrombosis and Hemostasis
1999
Corpus ID: 43707526
Low molecular weight heparin (LMWH) has challenged the position of unfractionated heparin (UFH) as the treatment of choice in…
Expand
Highly Cited
1995
Highly Cited
1995
TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin.
D. Hoppensteadt
,
J. Walenga
,
A. Fasanella
,
W. Jeske
,
J. Fareed
Thrombosis Research
1995
Corpus ID: 25066594
1995
1995
The Dose Proportionality of the Pharmacokinetics of Ardeparin, a Low Molecular Weight Heparin, in Healthy Volunteers
S. Troy
,
R. Fruncillo
,
T. Ozawa
,
E. Mammen
,
Scott Holloway
,
S. Chiang
Journal of clinical pharmacology
1995
Corpus ID: 8169918
Ardeparin is a low molecular weight heparin currently being evaluated as an antithrombotic agent. The objective of this…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE